SEC Form 4 · accession 0001013606-16-000194
ENDOLOGIX INC /DE/ · ELGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Cecile Ferracci
Officer — General Manager, Europe
Period of report
Feb 4, 2016
Accepted (ET)
Feb 17, 2016 · 4:18 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001013606
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common SharesF1 | Feb 4, 2016 | A | 11,952 | $0.00 | A | 40,706 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to PurchaseF2 | $7.53 | Feb 4, 2016 | A | 40,580 | A | Mar 4, 2016 | Feb 4, 2026 | Option to Purchase | 40,580 | 40,580 | D |
Explanation of responses
- F1Time based restricted stock unit award.
- F2Options vest ratably over forty-eight months.